About 1 in 8 Americans have used GLP-1s for weight loss — but more than three-quarters quit taking them within two years.
An early clinical trial suggests a minimally invasive procedure called duodenal mucosal resurfacing may reduce weight regain after people stop drugs such as semaglutide or tirzepatide. Patients who ...
Michael Cordova-Wang is a senior majoring in biology and public health and a 2020-21 health care ethics intern at the Markkula Center for Applied Ethics. Views are his own. The continued advancement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results